Lexicon Pharmaceuticals Inc (STU:LX31)
€ 4.096 0 (0%) Market Cap: 400.61 Mil Enterprise Value: 208.24 Mil PE Ratio: 0 PB Ratio: 1.81 GF Score: 51/100

Q4 2021 Lexicon Pharmaceuticals Inc Earnings Call Transcript

Feb 28, 2022 / 01:00PM GMT
Release Date Price: €4.1
Operator

Good morning. My name is April, and I will be your conference operator today.

At this time, I would like to welcome everyone to the Lexicon Pharmaceuticals Inc. Fourth Quarter 2021 Earnings Call.

(Operator Instructions)

I will now turn the call over to Chas Schultz. Please go ahead, sir.

Chas Schultz
Lexicon Pharmaceuticals, Inc. - Executive Director of Corporate Communications & Patient Advocacy

Thank you, April. Good morning, and welcome to the Lexicon Pharmaceuticals Fourth Quarter 2021 Financial Results Conference Call. Joining me today are Lonnel Coats, Lexicon's Chief Executive Officer; Jeff Wade, Lexicon's President and Chief Financial Officer; and Dr. Craig Granowitz, Lexicon's Senior Vice President and Chief Medical Officer.

Earlier this morning, Lexicon issued a press release announcing our financial results for the fourth quarter of 2021, which is available on our website at www.lexpharma.com and through our SEC filings. A webcast of this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot